The Journal of Infectious Diseases · 2015 · 70 citations · 10 references
Life SciencesInfectious DiseasesPharmacologyEmerging Infectious DiseasesMolecular VirologyVirologyAntiviral AgentsAntiviral Drug ResistanceAntiviral PharmacologyAntiviral ResistanceAntiviral TherapyViral InfectionsAntiviral Resistance MechanismsAntiviral TherapeuticsCombination Antiviral TherapyInfluenza Antiviral ResistanceInfluenza Antiviral TherapyInfluenza TreatmentMultidrug-resistant PathogensNeuraminidase Inhibitor Resistance
Prolonged treatment of an immunocompromised child with oseltamivir and zanamivir for A(H1N1)pdm09 virus infection led to the emergence of viruses carrying H275Y and/or E119G in the neuraminidase (NA). When phenotypically evaluated by NA inhibition, the dual H275Y-E119G substitution caused highly reduced inhibition by 4 NA inhibitors: oseltamivir, zanamivir, peramivir, and laninamivir.
10
Angela P. Campbell, Jason W. Chien, Jane Kuypers et al. · The Journal of Infectious Diseases · 2010 · 83 citations · Full text